Skip to main content
Top
Published in: BMC Cancer 1/2006

Open Access 01-12-2006 | Research article

Comparative effects of RRR-alpha- and RRR-gamma-tocopherol on proliferation and apoptosis in human colon cancer cell lines

Authors: Sharon E Campbell, William L Stone, Steven Lee, Sarah Whaley, Hongsong Yang, Min Qui, Paige Goforth, Devin Sherman, Derek McHaffie, Koyamangalath Krishnan

Published in: BMC Cancer | Issue 1/2006

Login to get access

Abstract

Background

Mediterranean societies, with diets rich in vitamin E isoforms, have a lower risk for colon cancer than those of northern Europe and the Americas. Vitamin E rich diets may neutralize free radicals generated by fecal bacteria in the gut and prevent DNA damage, but signal transduction activities can occur independent of the antioxidant function. The term vitamin E represents eight structurally related compounds, each differing in their potency and mechanisms of chemoprevention. The RRR-γ-tocopherol isoform is found primarily in the US diet, while RRR-α-tocopherol is highest in the plasma.

Methods

The effectiveness of RRR-α- and RRR-γ-tocopherol at inhibiting cell growth and inducing apoptosis in colon cancer cell lines with varying molecular characteristics (SW480, HCT-15, HCT-116 and HT-29) and primary colon cells (CCD-112CoN, nontransformed normal phenotype) was studied. Colon cells were treated with and without RRR-α- or RRR-γ-tocopherol using varying tocopherol concentrations and time intervals. Cell proliferation and apoptosis were measured using the trypan blue assay, annexin V staining, DNA laddering and caspase activation.

Results

Treatment with RRR-γ-tocopherol resulted in significant cell death for all cancer cell lines tested, while RRR-α-tocopherol did not. Further, RRR-γ-tocopherol treatment showed no cytotoxicity to normal colon cells CCD-112CoN at the highest concentration and time point tested. RRR-γ-tocopherol treatment resulted in cleavage of PARP, caspase 3, 7, and 8, but not caspase 9. Differences in the percentage cell death and apoptosis were observed in different cell lines suggesting that molecular differences in these cell lines may influence the ability of RRR-γ-tocopherol to induce cell death.

Conclusion

This is the first study to demonstrate that multiple colon cancer cell lines containing varying genetic alterations will under go growth reduction and apoptosis in the presence of RRR-γ-tocopherol without damage to normal colon cells. The amount growth reduction was dependent upon the molecular signatures of the cell lines. Since RRR-γ-tocopherol is effective at inhibition of cell proliferation at both physiological and pharmacological concentrations dietary RRR-γ-tocopherol may be chemopreventive, while pharmacological concentrations of RRR-γ-tocopherol may aid chemotherapy without toxic effects to normal cells demonstrated by most chemotherapeutic agents.
Appendix
Available only for authorised users
Literature
1.
go back to reference Potter JD: Nutrition and colorectal cancer. Cancer Causes Control. 1996, 1: 127-146. 10.1007/BF00115644.CrossRef Potter JD: Nutrition and colorectal cancer. Cancer Causes Control. 1996, 1: 127-146. 10.1007/BF00115644.CrossRef
2.
go back to reference Berrino F, Muti P: Mediterranean diet and cancer. Eur J Clin Nutr. 1989, 43: 49-55.PubMed Berrino F, Muti P: Mediterranean diet and cancer. Eur J Clin Nutr. 1989, 43: 49-55.PubMed
3.
go back to reference Khlat M: Cancer in Mediterranean migrants – based on studies in France and Australia. Cancer Causes Control. 1995, 6: 525-531. 10.1007/BF00054161.CrossRefPubMed Khlat M: Cancer in Mediterranean migrants – based on studies in France and Australia. Cancer Causes Control. 1995, 6: 525-531. 10.1007/BF00054161.CrossRefPubMed
4.
go back to reference Stone WL, Papas AM: Tocopherols and the etiology of colon cancer. J Natl Cancer Inst. 1997, 89: 1006-1014. 10.1093/jnci/89.14.1006.CrossRefPubMed Stone WL, Papas AM: Tocopherols and the etiology of colon cancer. J Natl Cancer Inst. 1997, 89: 1006-1014. 10.1093/jnci/89.14.1006.CrossRefPubMed
5.
go back to reference Campbell S, Stone W, Whaley S, Krishnan K: Development of gamma-tocopherol as a colorectal cancer chemopreventive agent. Critical Reviews in Oncology/Hematology. 2003, 47: 249-259. 10.1016/S1040-8428(03)00042-8.CrossRefPubMed Campbell S, Stone W, Whaley S, Krishnan K: Development of gamma-tocopherol as a colorectal cancer chemopreventive agent. Critical Reviews in Oncology/Hematology. 2003, 47: 249-259. 10.1016/S1040-8428(03)00042-8.CrossRefPubMed
6.
go back to reference Bostick RM, Potter JD, McKenzie DR, Sellers TA, Kushi LH, Steinmetz KA, Folsom AR: Reduced risk of colon cancer with high intake of vitamin E: the Iowa Women's Health Study. Cancer Res. 1993, 53: 4230-4237.PubMed Bostick RM, Potter JD, McKenzie DR, Sellers TA, Kushi LH, Steinmetz KA, Folsom AR: Reduced risk of colon cancer with high intake of vitamin E: the Iowa Women's Health Study. Cancer Res. 1993, 53: 4230-4237.PubMed
7.
go back to reference Helzlsouer KJ, Huang HY, Alberg AJ, Hoffman S, Burke A, Norkus EP, Morris JS, Comstock GW: Association between alpha-tocopherol, gamma-tocopherol, selenium, and subsequent prostate cancer. J Natl Cancer Inst. 2000, 92: 2018-2022. 10.1093/jnci/92.24.2018.CrossRefPubMed Helzlsouer KJ, Huang HY, Alberg AJ, Hoffman S, Burke A, Norkus EP, Morris JS, Comstock GW: Association between alpha-tocopherol, gamma-tocopherol, selenium, and subsequent prostate cancer. J Natl Cancer Inst. 2000, 92: 2018-2022. 10.1093/jnci/92.24.2018.CrossRefPubMed
8.
go back to reference Ingles SA, Bird CL, Shikany JM, Frankl HD, Lee ER, Haile RW: Plasma tocopherol and prevalence of colorectal adenomas in a multiethnic population. Cancer Res. 1998, 58: 661-666.PubMed Ingles SA, Bird CL, Shikany JM, Frankl HD, Lee ER, Haile RW: Plasma tocopherol and prevalence of colorectal adenomas in a multiethnic population. Cancer Res. 1998, 58: 661-666.PubMed
9.
go back to reference Steele VE, Moon RC, Lubet RA, Grubbs CJ, Reddy BS, Wargovich M, McCormick DL, Pereira MA, Crowell JA, Bagheri D.: Preclinical efficacy evaluation of potential chemopreventive agents in animal carcinogenesis models: methods and results from the NCI Chemoprevention Drug Development Program. J Cell Biochem Suppl. 1994, 20: 32-54. 10.1002/jcb.240560905.CrossRefPubMed Steele VE, Moon RC, Lubet RA, Grubbs CJ, Reddy BS, Wargovich M, McCormick DL, Pereira MA, Crowell JA, Bagheri D.: Preclinical efficacy evaluation of potential chemopreventive agents in animal carcinogenesis models: methods and results from the NCI Chemoprevention Drug Development Program. J Cell Biochem Suppl. 1994, 20: 32-54. 10.1002/jcb.240560905.CrossRefPubMed
10.
go back to reference Stone WL, Papas AM, LeClair IO, Qui M, Ponder T: The influence of dietary iron and tocopherols on oxidative stress and ras-p21 levels in the colon. Cancer Detect Prev. 2002, 26: 78-84. 10.1016/S0361-090X(02)00003-X.CrossRefPubMed Stone WL, Papas AM, LeClair IO, Qui M, Ponder T: The influence of dietary iron and tocopherols on oxidative stress and ras-p21 levels in the colon. Cancer Detect Prev. 2002, 26: 78-84. 10.1016/S0361-090X(02)00003-X.CrossRefPubMed
11.
go back to reference Himmelfarb J, Kane J, McMonagle E, Zaltas E, Bobzin S, Boddupalli S, Phinney S, Miller G: Alpha and gamma tocopherol metabolism in healthy subjects and patients with end-stage renal disease. Kidney Int. 2005, 64: 978-991. 10.1046/j.1523-1755.2003.00151.x.CrossRef Himmelfarb J, Kane J, McMonagle E, Zaltas E, Bobzin S, Boddupalli S, Phinney S, Miller G: Alpha and gamma tocopherol metabolism in healthy subjects and patients with end-stage renal disease. Kidney Int. 2005, 64: 978-991. 10.1046/j.1523-1755.2003.00151.x.CrossRef
12.
go back to reference Cooney RV, Harwood PJ, Franke AA, Narala K, Sundstrom AK, Berggren PO, Mordan LJ: Products of gamma-tocopherol reaction with NO2 and their formation in rat insulinoma (RINm5F) cells. Free Radic Biol Med. 1995, 19: 259-269. 10.1016/0891-5849(95)00019-T.CrossRefPubMed Cooney RV, Harwood PJ, Franke AA, Narala K, Sundstrom AK, Berggren PO, Mordan LJ: Products of gamma-tocopherol reaction with NO2 and their formation in rat insulinoma (RINm5F) cells. Free Radic Biol Med. 1995, 19: 259-269. 10.1016/0891-5849(95)00019-T.CrossRefPubMed
13.
go back to reference Jiang Q, Elson-Schwab I, Courtemanche C, Ames BN: Gamma-tocopherol and its major metabolite, in contrast to alpha-tocopherol, inhibit cyclooxygenase activity in macrophages and epithelial cells. Proc Natl Acad Sci U S A. 2000, 97: 11494-11499. 10.1073/pnas.200357097.CrossRefPubMedPubMedCentral Jiang Q, Elson-Schwab I, Courtemanche C, Ames BN: Gamma-tocopherol and its major metabolite, in contrast to alpha-tocopherol, inhibit cyclooxygenase activity in macrophages and epithelial cells. Proc Natl Acad Sci U S A. 2000, 97: 11494-11499. 10.1073/pnas.200357097.CrossRefPubMedPubMedCentral
14.
go back to reference Gysin R, Azzi A, Visarius T: Gamma tocopherol inhibits human cancer cell cycle progression and cell proliferation by down-regulation of cyclins. FASEB J. 2002, 16: 1952-1954.PubMed Gysin R, Azzi A, Visarius T: Gamma tocopherol inhibits human cancer cell cycle progression and cell proliferation by down-regulation of cyclins. FASEB J. 2002, 16: 1952-1954.PubMed
15.
go back to reference Gao R, Stone WL, Huang T, Papas AM, Qui M: The uptake of tocopherols by RAW 264.7 macrophages. Nutr J. 2002 Gao R, Stone WL, Huang T, Papas AM, Qui M: The uptake of tocopherols by RAW 264.7 macrophages. Nutr J. 2002
16.
go back to reference Moyad MA, Brumfield SK, Pienta KJ: Vitamin E, alpha- and gamma-tocopherol, and prostate cancer. Semin Urol Oncol. 1999, 17: 85-90.PubMed Moyad MA, Brumfield SK, Pienta KJ: Vitamin E, alpha- and gamma-tocopherol, and prostate cancer. Semin Urol Oncol. 1999, 17: 85-90.PubMed
17.
go back to reference Weber T, Lu M, Andera L, Lahm H, Gellert N, Fariss MW, Korinek V, Sattler W, Ucker DS, Terman A, Schroder A, Erl W, Brunk UT, Coffey RJ, Weber C, Neuzil J: Vitamin E succinate is a potent novel antineoplastic agent with high selectivity and cooperativity with tumor necrosis factor-related apoptosis-inducing ligand (Apo2 ligand) in vivo. Clin Cancer Res. 2002, 8: 863-869.PubMed Weber T, Lu M, Andera L, Lahm H, Gellert N, Fariss MW, Korinek V, Sattler W, Ucker DS, Terman A, Schroder A, Erl W, Brunk UT, Coffey RJ, Weber C, Neuzil J: Vitamin E succinate is a potent novel antineoplastic agent with high selectivity and cooperativity with tumor necrosis factor-related apoptosis-inducing ligand (Apo2 ligand) in vivo. Clin Cancer Res. 2002, 8: 863-869.PubMed
18.
go back to reference Zu K, Ip C: Synergy between Selenium and Vitamin E in apoptosis induction is associated with activation of distinctive initiator caspases in human prostate cancer cells. Cancer Research. 2003, 63: 6988-6995.PubMed Zu K, Ip C: Synergy between Selenium and Vitamin E in apoptosis induction is associated with activation of distinctive initiator caspases in human prostate cancer cells. Cancer Research. 2003, 63: 6988-6995.PubMed
19.
go back to reference Neuzil J, Weber T, Schroder A, Lu M, Ostermann G, Gellert N, Mayne G, Olenjnicka B, Negre-salvayre A, Sticha M, Coffey R, Weber C: Induction of cancer cell apoptosis by alpha tocopheryl succinate: molecular pathways and structural requirements. FASEB. 2002, 15: 403-412. 10.1096/fj.00-0251com.CrossRef Neuzil J, Weber T, Schroder A, Lu M, Ostermann G, Gellert N, Mayne G, Olenjnicka B, Negre-salvayre A, Sticha M, Coffey R, Weber C: Induction of cancer cell apoptosis by alpha tocopheryl succinate: molecular pathways and structural requirements. FASEB. 2002, 15: 403-412. 10.1096/fj.00-0251com.CrossRef
20.
go back to reference Galli F, Stabile AM, Betti M, Conte C, Pistilli A, Rende M, Floridi A, Azzi A: The effect of [alpha]- and [gamma]-tocopherol and their carboxyethyl hydroxychroman metabolites on prostate cancer cell proliferation. Archives of Biochemistry and Biophysics. 2004, 423: 97-102. 10.1016/j.abb.2003.11.014.CrossRefPubMed Galli F, Stabile AM, Betti M, Conte C, Pistilli A, Rende M, Floridi A, Azzi A: The effect of [alpha]- and [gamma]-tocopherol and their carboxyethyl hydroxychroman metabolites on prostate cancer cell proliferation. Archives of Biochemistry and Biophysics. 2004, 423: 97-102. 10.1016/j.abb.2003.11.014.CrossRefPubMed
21.
go back to reference Anderson K, Simmons-Menchaca M, Lawson KA, Atkinson J, Sanders BG, Kline K: Differential response of human ovarian cancer cells to induction of apoptosis by Vitamin E Succinate and Vitamin E Analogue, {alpha}-TEA. Cancer Research. 2004, 64: 4263-4269. 10.1158/0008-5472.CAN-03-2327.CrossRefPubMed Anderson K, Simmons-Menchaca M, Lawson KA, Atkinson J, Sanders BG, Kline K: Differential response of human ovarian cancer cells to induction of apoptosis by Vitamin E Succinate and Vitamin E Analogue, {alpha}-TEA. Cancer Research. 2004, 64: 4263-4269. 10.1158/0008-5472.CAN-03-2327.CrossRefPubMed
22.
go back to reference Campbell SE, Stone WL, Whaley SG, Qui M, Krishnan K: Gamma tocopherol upregulates peroxisome proliferator activated receptor (PPAR) gamma expression in SW 480 human colon cancer cell lines. BMC Cancer. 2003, 3: Campbell SE, Stone WL, Whaley SG, Qui M, Krishnan K: Gamma tocopherol upregulates peroxisome proliferator activated receptor (PPAR) gamma expression in SW 480 human colon cancer cell lines. BMC Cancer. 2003, 3:
23.
go back to reference Podda M, Weber C, Traber MG, Milbradt R, Packer L: Sensitive high-performance liquid chromatography techniques for simultaneous determination of tocopherols, tocotrienols, ubiquinols, and ubiquinones in biological samples. Methods Enzymol. 1999, 299: 330-341.CrossRefPubMed Podda M, Weber C, Traber MG, Milbradt R, Packer L: Sensitive high-performance liquid chromatography techniques for simultaneous determination of tocopherols, tocotrienols, ubiquinols, and ubiquinones in biological samples. Methods Enzymol. 1999, 299: 330-341.CrossRefPubMed
24.
go back to reference Stone WL, Smith M: Therapeutic uses of antioxidant liposomes. Mol Biotechnol. 2004, 27: 217-230. 10.1385/MB:27:3:217.CrossRefPubMed Stone WL, Smith M: Therapeutic uses of antioxidant liposomes. Mol Biotechnol. 2004, 27: 217-230. 10.1385/MB:27:3:217.CrossRefPubMed
25.
go back to reference Nair PP, Lohani A, Norkus EP, Feagins H, Bhagavan HN: Uptake and distribution of carotenoids, retinol, and tocopherols in human colonic epithelial cells in vivo. Cancer Epidemiol Biomarkers Prev. 1996, 5: 913-916.PubMed Nair PP, Lohani A, Norkus EP, Feagins H, Bhagavan HN: Uptake and distribution of carotenoids, retinol, and tocopherols in human colonic epithelial cells in vivo. Cancer Epidemiol Biomarkers Prev. 1996, 5: 913-916.PubMed
26.
go back to reference Krysan K, Dalwadi H, Sharma S, Pold M, Dubinett S: Cyclooxygenase 2-dependent expression of survivin is critical for apoptosis resistance in non-small cell lung cancer. Cancer Research. 2004, 64: 6359-6362. 10.1158/0008-5472.CAN-04-1681.CrossRefPubMed Krysan K, Dalwadi H, Sharma S, Pold M, Dubinett S: Cyclooxygenase 2-dependent expression of survivin is critical for apoptosis resistance in non-small cell lung cancer. Cancer Research. 2004, 64: 6359-6362. 10.1158/0008-5472.CAN-04-1681.CrossRefPubMed
27.
go back to reference Li H, Pamukcu R, Thompson WJ: Beta-catenin signaling: therapeutic strategies in oncology. Cancer Biol Ther. 2002, 1: 621-625.CrossRefPubMed Li H, Pamukcu R, Thompson WJ: Beta-catenin signaling: therapeutic strategies in oncology. Cancer Biol Ther. 2002, 1: 621-625.CrossRefPubMed
28.
go back to reference Jiang Q, Wong J, Fyrst H, Saba JD, Ames BN: Gamma-tocopherol or combinations of vitamin E forms induce cell death in human prostate cancer cells by interrupting sphingolipid synthesis. Proceedings of the National Academy of Sciences. 2004, 101: 17825-17830. 10.1073/pnas.0408340102.CrossRef Jiang Q, Wong J, Fyrst H, Saba JD, Ames BN: Gamma-tocopherol or combinations of vitamin E forms induce cell death in human prostate cancer cells by interrupting sphingolipid synthesis. Proceedings of the National Academy of Sciences. 2004, 101: 17825-17830. 10.1073/pnas.0408340102.CrossRef
29.
go back to reference Andrieu-Abadie N, Gouaze V, Salvayre R, Levade T: Ceramide in apoptosis signaling: relationship with oxidative stress. Free Radical Biology and Medicine. 2001, 31: 717-728. 10.1016/S0891-5849(01)00655-4.CrossRefPubMed Andrieu-Abadie N, Gouaze V, Salvayre R, Levade T: Ceramide in apoptosis signaling: relationship with oxidative stress. Free Radical Biology and Medicine. 2001, 31: 717-728. 10.1016/S0891-5849(01)00655-4.CrossRefPubMed
30.
go back to reference Macchia M, Bertini S, Fogli S, Giovannetti E, Minutolo F, Rapposelli S, Romano D: Ceramide analogues in apoptosis: a new strategy for anticancer drug development. Il Farmaco. 2003, 58: 205-211. 10.1016/S0014-827X(03)00015-6.CrossRefPubMed Macchia M, Bertini S, Fogli S, Giovannetti E, Minutolo F, Rapposelli S, Romano D: Ceramide analogues in apoptosis: a new strategy for anticancer drug development. Il Farmaco. 2003, 58: 205-211. 10.1016/S0014-827X(03)00015-6.CrossRefPubMed
31.
go back to reference Levade T, Malagarie-Cazenave S, Gouaze V, Segui B, Tardy C, Betito S, Andrieu-Abadie N, Cuvillier O: Ceramide in apoptosis: a revisited role. Neurochem Res. 2002, 27: 601-607. 10.1023/A:1020215815013.CrossRefPubMed Levade T, Malagarie-Cazenave S, Gouaze V, Segui B, Tardy C, Betito S, Andrieu-Abadie N, Cuvillier O: Ceramide in apoptosis: a revisited role. Neurochem Res. 2002, 27: 601-607. 10.1023/A:1020215815013.CrossRefPubMed
32.
go back to reference Ogretmen B, Hannun YA: Biologically active sphingolipids in cancer pathogenesis and treatment. Nat Rev Cancer. 2004, 4: 604-616. 10.1038/nrc1411.CrossRefPubMed Ogretmen B, Hannun YA: Biologically active sphingolipids in cancer pathogenesis and treatment. Nat Rev Cancer. 2004, 4: 604-616. 10.1038/nrc1411.CrossRefPubMed
33.
go back to reference Rumi MA, Ishihara S, Kazumori H, Kadowaki Y, Kinoshita Y: Can PPAR gamma ligands be used in cancer therapy?. Curr Med Chem Anti-Canc Agents. 2004, 4: 465-477. 10.2174/1568011043352678.CrossRef Rumi MA, Ishihara S, Kazumori H, Kadowaki Y, Kinoshita Y: Can PPAR gamma ligands be used in cancer therapy?. Curr Med Chem Anti-Canc Agents. 2004, 4: 465-477. 10.2174/1568011043352678.CrossRef
34.
go back to reference Yoshimura R, Matsuyama M, Hase T, Tsuchida K, Kuratsukuri K, Kawahito Y, Sano H, Segawa Y, Nakatani T: The effect of peroxisome proliferator-activated receptor-gamma ligand on urological cancer cells. Int J Mol Med. 2003, 12: 861-865.PubMed Yoshimura R, Matsuyama M, Hase T, Tsuchida K, Kuratsukuri K, Kawahito Y, Sano H, Segawa Y, Nakatani T: The effect of peroxisome proliferator-activated receptor-gamma ligand on urological cancer cells. Int J Mol Med. 2003, 12: 861-865.PubMed
35.
go back to reference Segawa Y, Yoshimura R, Hase T, Nakatani T, Wada S, Kawahito Y, Kishimoto H, Sano H: Expression of peroxisome proliferator-activated receptor (PPAR) in human prostate cancer. Prostate. 2002, 51: 108-116. 10.1002/pros.10058.CrossRefPubMed Segawa Y, Yoshimura R, Hase T, Nakatani T, Wada S, Kawahito Y, Kishimoto H, Sano H: Expression of peroxisome proliferator-activated receptor (PPAR) in human prostate cancer. Prostate. 2002, 51: 108-116. 10.1002/pros.10058.CrossRefPubMed
36.
go back to reference Hase T, Yoshimura R, Mitsuhashi M, Segawa Y, Kawahito Y, Wada S, Nakatani T, Sano H: Expression of peroxisome proliferator-activated receptors in human testicular cancer and growth inhibition by its agonists. Urology. 2002, 60: 542-547. 10.1016/S0090-4295(02)01747-8.CrossRefPubMed Hase T, Yoshimura R, Mitsuhashi M, Segawa Y, Kawahito Y, Wada S, Nakatani T, Sano H: Expression of peroxisome proliferator-activated receptors in human testicular cancer and growth inhibition by its agonists. Urology. 2002, 60: 542-547. 10.1016/S0090-4295(02)01747-8.CrossRefPubMed
37.
go back to reference Bull AW: The role of peroxisome proliferator-activated receptor gamma in colon cancer and inflammatory bowel disease. Arch Pathol Lab Med. 2003, 127: 1121-1123.PubMed Bull AW: The role of peroxisome proliferator-activated receptor gamma in colon cancer and inflammatory bowel disease. Arch Pathol Lab Med. 2003, 127: 1121-1123.PubMed
38.
go back to reference Li MY, Deng H, Zhao JM, Dai D, Tan XY: Peroxisome proliferator-activated receptor gamma ligands inhibit cell growth and induce apoptosis in human liver cancer BEL-7402 cells. World J Gastroenterol. 2003, 9: 1683-1688.CrossRefPubMedPubMedCentral Li MY, Deng H, Zhao JM, Dai D, Tan XY: Peroxisome proliferator-activated receptor gamma ligands inhibit cell growth and induce apoptosis in human liver cancer BEL-7402 cells. World J Gastroenterol. 2003, 9: 1683-1688.CrossRefPubMedPubMedCentral
Metadata
Title
Comparative effects of RRR-alpha- and RRR-gamma-tocopherol on proliferation and apoptosis in human colon cancer cell lines
Authors
Sharon E Campbell
William L Stone
Steven Lee
Sarah Whaley
Hongsong Yang
Min Qui
Paige Goforth
Devin Sherman
Derek McHaffie
Koyamangalath Krishnan
Publication date
01-12-2006
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2006
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-6-13

Other articles of this Issue 1/2006

BMC Cancer 1/2006 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine